Abstract
In this issue of Blood, Akhtari et al present a retrospective analysis of baseline positron emission tomography-computed tomography (PET-CT) in Hodgkin lymphoma (HL) in relation to the prognostic significance of the metabolic tumor volume (MTV) in risk classification of early-stage HL.1 These measurements yield estimates of the total tumor burden, which has previously been demonstrated to be one of the most significant prognostic factor in HL.2 A more precise discrimination between low-risk vs high-risk HL using baseline PET-CT characteristics could be clinically useful and might inform treatment decisions.
| Original language | English |
|---|---|
| Pages (from-to) | 3-4 |
| Number of pages | 2 |
| Journal | Blood |
| Volume | 131 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 4 Jan 2018 |